Royalty Pharma (RPRX) Insider Trading & Ownership $53.55 +0.49 (+0.92%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$52.11 -1.44 (-2.69%) As of 05/21/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Royalty Pharma (NASDAQ:RPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.84%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$59.53M Get RPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Royalty Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RPRX Insider Buying and Selling by Quarter Royalty Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2026Gregory NordenDirectorSell3,045$53.00$161,385.00 5/14/2026Marshall UristEVPSell13,684$53.06$726,073.04 4/28/2026Terrance P CoyneCFOSell34,791$49.78$1,731,895.98 4/1/2026Terrance P CoyneCFOSell34,791$48.33$1,681,449.03 3/23/2026Terrance P CoyneCFOSell34,791$45.53$1,584,034.23 3/2/2026Terrance P CoyneCFOSell34,791$46.78$1,627,522.98 2/4/2026Terrance P CoyneCFOSell20,163$43.29$872,856.27 2/3/2026Terrance P CoyneCFOSell114,954$42.84$4,924,629.36 2/2/2026Terrance P CoyneCFOSell108,424$42.08$4,562,481.92 1/30/2026Marshall UristEVPSell20,000$41.09$821,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/23/2026Marshall UristEVPSell20,000$40.26$805,200.00 1/20/2026Terrance P CoyneCFOSell69,582$39.35$2,738,051.70 1/16/2026Marshall UristEVPSell20,000$39.52$790,400.00 1/9/2026Marshall UristEVPSell20,000$40.78$815,600.00 1/2/2026Terrance P CoyneCFOSell69,582$38.42$2,673,340.44 12/26/2025Marshall UristEVPSell20,000$39.32$786,400.00 12/19/2025Marshall UristEVPSell20,000$38.38$767,600.00 12/18/2025George W LloydEVPSell30,654$38.50$1,180,179.00 12/17/2025George W LloydEVPSell79,346$38.57$3,060,375.22 12/16/2025Marshall UristEVPSell20,000$38.32$766,400.00 12/15/2025Terrance P CoyneCFOSell69,582$38.36$2,669,165.52 12/5/2025Marshall UristEVPSell18,242$39.15$714,174.30 12/5/2025Marshall UristEVPSell23,334$39.15$913,526.10 12/3/2025George W LloydEVPSell110,000$39.77$4,374,700.00 12/1/2025Marshall UristEVPSell18,242$39.90$727,855.80 12/1/2025Marshall UristEVPSell23,333$39.93$931,686.69 12/1/2025Terrance P CoyneCFOSell69,582$39.87$2,774,234.34 11/24/2025Terrance P CoyneCFOSell69,582$38.55$2,682,386.10 11/19/2025George W LloydEVPSell3,000$38.34$115,020.00 11/19/2025George W LloydEVPSell132,426$38.34$5,077,212.84 11/17/2025Terrance P CoyneCFOSell69,594$39.30$2,735,044.20 11/17/2025Terrance P CoyneCFOSell69,594$39.30$2,735,044.20 (Data available from 1/1/2013 forward) RPRX Insider Trading Activity - Frequently Asked Questions Who is on Royalty Pharma's Insider Roster? The list of insiders at Royalty Pharma includes Avara Management Ltd, George W Lloyd, Gregory Norden, Marshall Urist, Pablo G Legorreta, Rory B Riggs, and Terrance P Coyne. Learn more on insiders at RPRX. What percentage of Royalty Pharma stock is owned by insiders? 18.84% of Royalty Pharma stock is owned by insiders. Learn more on RPRX's insider holdings. Which Royalty Pharma insiders have been selling company stock? The following insiders have sold RPRX shares in the last 24 months: George W Lloyd ($13,807,487.06), Gregory Norden ($161,385.00), Marshall Urist ($10,288,546.93), and Terrance P Coyne ($35,992,136.27). How much insider selling is happening at Royalty Pharma? Insiders have sold a total of 1,478,793 Royalty Pharma shares in the last 24 months for a total of $60,249,555.26 sold. Royalty Pharma Active InsidersPablo G Legorreta (Age 61)Founder & Chief Executive Officer and ChairmanTerrance P Coyne (Age 43)CFO12 recent tradesRory B RiggsDirectorWilliam E FordDirectorHenry A FernandezDirectorMario Germano GiulianiDirectorGregory NordenDirector1 recent tradesGeorge W Lloyd (Age 66)EVP3 recent tradesJames F Reddoch (Age 56)EVPMarshall UristEVP12 recent tradesSanjay Kumar SinghCRO More Insider Trading Tools from MarketBeat Related Companies Bristol Myers Squibb Insider Buying Zoetis Insider Buying Jazz Pharmaceuticals Insider Buying Corcept Therapeutics Insider Buying Supernus Pharmaceuticals Insider Buying Nektar Therapeutics Insider Buying Perrigo Insider Buying Pacira BioSciences Insider Buying Omeros Insider Buying Assembly Biosciences Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:RPRX) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredHidden on Tesla's filing: A $12 billion "super startup"Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon M...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...Equiscreen | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
